Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

12.630
+1.64014.92%
Volume:- -
Turnover:- -
Market Cap:32.43B
PE:20.05
High:12.630
Open:12.630
Low:12.630
Close:10.990
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:- -
T/O Rate:- -
Dividend:0.21
Dividend Rate:1.66%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.95
PE(LYR):20.05
PS:3.19

Loading ...

Simcere Pharma cancels 27.50 million shares, cutting outstanding stock by 1.06%

Bulletin Express
·
Jun 08

SIMCERE PHARMA Cancels Nearly 27.5 Million Repurchased Shares

Stock News
·
Jun 08

Simcere Pharmaceutical files HKEX next-day disclosure, reports share buyback at HKD 11.42/share

Reuters
·
Jun 08

Simcere Pharma Reports Stable Share Base in May 2026; Public Float Remains Above 15.45% Threshold

Bulletin Express
·
Jun 03

Simcere Pharma Wins Promotion Rights for PrimeGenX's Atopic Dermatitis Drug

MT Newswires Live
·
Jun 02

BRIEF-Simcere Pharmaceutical Enters Exclusive Promotion Service Agreement With Primegenx Therapeutics

Reuters
·
Jun 01

Simcere Pharma, PrimeGenX Ink Exclusive Promotion Deal for Pumecitinib Gel in Greater China

Bulletin Express
·
Jun 01

SIMCERE PHARMA Secures Exclusive Rights to Promote Pemecitinib Gel

Stock News
·
Jun 01

Simcere signs exclusive promotion pact with PrimeGenX for pumecitinib gel in Greater China

Reuters
·
Jun 01

Simcere Pharmaceutical - Obtains Exclusive Promotion Rights for Pumecitinib Gel in China, Hong Kong, Macau

THOMSON REUTERS
·
Jun 01

Simcere Pharmaceutical - - Entering Into an Exclusive Promotion Service Agreement With Primegenx Therapeutics

THOMSON REUTERS
·
Jun 01

SIMCERE PHARMA Executes HK$8.7 Million Share Buyback on May 22

Deep News
·
May 25

SIMCERE PHARMA Spends HK$8.7 Million on Share Buyback

Stock News
·
May 22

Simcere Pharma adds 0.83 million-share buyback; 27.50 million shares now pending cancellation, 1.11% of capital

Bulletin Express
·
May 22

Simcere files HKEX next-day return, discloses share repurchase at HKD 10.49 each

Reuters
·
May 22

Simcere Pharma Releases AGM Circular and Switches to Fully Electronic Corporate Communications

Bulletin Express
·
May 21

Simcere Pharma Sets 12 June 2026 AGM; Board Seeks Approval for RMB0.18 Final Dividend, 20% Issuance Mandate and 10% Buyback Limit

Bulletin Express
·
May 21

Simcere Releases AGM Circular and Adopts Full e-Communication Framework

Bulletin Express
·
May 21

Simcere Pharma Plans 20% Share Issue Mandate, 10% Buyback, RMB0.18 Final Dividend and Board Changes Ahead of 12 June 2026 AGM

Bulletin Express
·
May 21

Simcere Pharma Issues AGM Notice, Proposes RMB0.18 Final Dividend and Director Re-election

Bulletin Express
·
May 21